APPLICATION OF ERYTHROPOIETIN THETA IN THERAPY OF ANEMIA IN ONCOLOGIC PATIENTS

per O. A. GLADKOV, A. V. SNEGOVOY
Publicat 2016-12-01

SYSTEMATIC AND SAMPLING MEDIASTINAL LYMPH NODE DISSECTION OF COMBINED TREATMENT OF NON-SMALL CELLS LUNG CANCER IIIA(N2) STAGE

per E. O. Mantsyrev, A. V. Vazhenin, O. A. Gladkov, A. A. Lukin, M. N. Mironchenko, Ya. A. Gnatiuk, S. N. Timofeev
Publicat 2017-02-01

EFFECT OF THE EXTENT OF MEDIASTINAL LYMPHODISSECTION ON THE RESULTS OF COMBINED MODALITY TREATMENT FOR STAGE IIIA (N2 ) NON-SMALL CELL LUNG CANCER

per E. O. Mantsyrev, A. V. Vazhenin, O. A. Gladkov, A. A. Lukin, M. N. Mironchenko, Ya. A. Gnatyuk, S. N. Timofeev
Publicat 2016-02-01

Toxicity and efficacy of biosimilar bevacizumab in the second-line therapy for metastatic colon cancer in routine clinical practice: results of an independent observational study

per M.   Yu. Fedyanin, F.   V. Moiseenko, M.   A. Lyadova, V.  N.  Vorobyeva, V.  V.  Petkau, A.  V.  Fateeva, E.  S.  Kuzmina, O.  Yu.  Novikova, V.   A. Chubenko, N.  Kh.  Abduloeva, A.  A.  Kudryavtsev, E.   O. Ignatova, R.   R. Shakirov, O.  A.  Pardabekova, L.  V.  Kindyalova, S.  P.  Pelikh, O.   A. Gladkov, S.  A.  Tjulandin, A.  A.  Tryakin
Publicat 2021-06-01